Experiences with
Obeticholic acid4,275 public posts
update on OCA
For the latest update on Obeticholic Acid in Europe click here: https://www.pbcfoundation.org.uk/obeticholic-acid-in-europe/
#PBC #SupportforLife
Ask Your Questions
Prof David Jones is our guest for tomorrows #PBC Q&A joined by the #PBCTeam live from the obeticholic acid protest in Brussels! Click here for the privacy of the room: https://www.pbcfoundation.org.uk/events/qa-pbc/ or watch us on Facebook Live at 2pm UK time.
Want to take advantage of all our features? Just log in!
or
Posted on The PBC Foundation FB page
Prof David Jones talks us through the current situation around the future of obeticholic acid (OCA) in Europe and what this means.
PBC Foundation Update regarding Ocaliva
Obeticholic Acid in Europe
29/6/2024
We are issuing this guidance in response to the announcement made by the European Medicines Agency (EMA) on 28th June 2024 about the future of obeticholic acid (OCA or Ocaliva) in Europe.
Good news for OCA patients
Read all about it here: https://www.pbcfoundation.org.uk/obeticholic-acid-in-europe/
One piece at a time.....
The major changes from the last guideline to this guidance include information about obeticholic acid (OCA) and the adaptation of the guidance format.
Two updates in the Guidelines for PBC
The major changes from the last guidance to this guidance include information about obeticholic acid (OCA).
Important from The PBC Foundation....
We are emphasising two things in this letter: 1) That Obeticholic Acid, aka OCA or Ocaliva continues to have a license, even if it is still conditional, as a treatment for PBC.
Wednesday's Word
The only approved second line treatment is the use of Ovaliva ( acid) . Bezafibrates (fenofibrates in the US) have been used as well along with Ocaliva but neither of these drug groups are licensed yet. Right now they are being used in clinical trials.